Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia

作者: Steven N. Singh , Ross D. Fletcher , Susan Gross Fisher , Bramah N. Singh , H. Daniel Lewis

DOI: 10.1056/NEJM199507133330201

关键词:

摘要: Background Asymptomatic ventricular arrhythmias in patients with congestive heart failure are associated increased rates of overall mortality and sudden death. Amiodarone is now used widely to prevent tachycardia fibrillation. We conducted a trial determine whether amiodarone can reduce asymptomatic arrhythmias. Methods double-blind, placebo-controlled protocol which 674 symptoms failure, cardiac enlargement, 10 or more premature contractions per hour, left ejection fraction 40 percent less were randomly assigned receive (336 patients) placebo (338 patients). The primary end point was mortality, the median follow-up 45 months (range, 0 54). Results There no significant difference between two treatment groups (P = 0.6). two-year actuarial survival rate 69...

参考文章(24)
John M Nicklas, William J McKenna, Ralph A Stewart, Judith K Mickelson, Sunil K Das, M.Anthony Schork, Shirley J Krikler, Laurie A Quain, Fred Morady, Bertram Pitt, Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy American Heart Journal. ,vol. 122, pp. 1016- 1021 ,(1991) , 10.1016/0002-8703(91)90466-U
Angas W.F. Hamer, L. Barry Arkles, Jennifer A. Johns, Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: A placebo-controlled trial Journal of the American College of Cardiology. ,vol. 14, pp. 1768- 1774 ,(1989) , 10.1016/0735-1097(89)90030-2
HernanC Doval, DanielR Nul, HugoO Grancelli, SergioV Perrone, GuillermoR Bortman, Rodolfo Curiel, Randomised trial of low-dose amiodarone in severe congestive heart failure The Lancet. ,vol. 344, pp. 493- 498 ,(1994) , 10.1016/S0140-6736(94)91895-3
Donald V. Unverferth, Raymond D. Magorien, Melvin L. Moeschberger, Peter B. Baker, Julie K. Fetters, Carl V. Leier, Factors influencing the one-year mortality of dilated cardiomyopathy. American Journal of Cardiology. ,vol. 54, pp. 147- 152 ,(1984) , 10.1016/0002-9149(84)90320-5
Steven N. Singh, Ross D. Fletcher, Susan Fisher, Diane Lazzeri, Prakash Deedwania, Daniel Lewis, Barry Massie, Bramah N. Singh, Cindy Colling, The CHF STAT Investigators, Veterans affairs congestive heart failure antiarrhythmic trial The American Journal of Cardiology. ,vol. 72, pp. F99- F102 ,(1993) , 10.1016/0002-9149(93)90971-E
John M. Herre, Mary Jane Sauve, Patricia Malone, Jerry C. Griffin, Ibrahim Helmy, Jonathan J. Langberg, Harold Goldberg, Melvin M. Scheinman, Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation Journal of the American College of Cardiology. ,vol. 13, pp. 442- 449 ,(1989) , 10.1016/0735-1097(89)90525-1
Thomas Meinertz, Thomas Hofmann, Wolfgang Kasper, Norbert Treese, Heinrich Bechtold, Ulrich Stenen, Tiberius Pop, Enz-Rüdiger V. Leitner, Dietrich Andresen, Jürgen Meyer, Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy The American Journal of Cardiology. ,vol. 53, pp. 902- 907 ,(1984) , 10.1016/0002-9149(84)90522-8
H Cingolani, Negative lusitropic effect of DPI 201-106 and E4031. Possible role of prolonging action potential duration Journal of Molecular and Cellular Cardiology. ,vol. 22, pp. 1025- 1034 ,(1990) , 10.1016/0022-2828(90)91042-6